Understanding How Special Immune Cells Fight HIV
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
This research explores how a unique type of immune cell, called natural killer (NK) cells, learns to specifically target and fight HIV in people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11137750 on NIH RePORTER |
What this research studies
Current approaches to combat HIV often focus on T cells, B cells, and antibodies, but this work highlights the potential of NK cells to respond quickly and powerfully to HIV. While NK cells are typically seen as general defenders, recent findings show that some NK cells can develop adaptive functions, meaning they can remember and specifically target certain threats, much like T and B cells. Our team has found evidence of these 'adaptive' NK cells in humans exposed to HIV, suggesting they could be a key part of the body's defense. This project aims to uncover the precise ways these adaptive NK cells develop their ability to recognize and fight HIV.
Who could benefit from this research
Good fit: This foundational research is relevant to individuals living with HIV or those at risk of HIV exposure, as it seeks to understand the body's immune response.
Not a fit: Patients not affected by HIV or SIV would not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this research could lead to new strategies for preventing, controlling, or even eradicating HIV by harnessing the powerful, adaptive abilities of NK cells.
How similar studies have performed: Previous studies have shown that NK cells in primates and humans can develop adaptive immune functions, including antigen-specific memory against HIV/SIV, supporting this novel approach.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Reeves, Roger Keith — Duke University
- Study coordinator: Reeves, Roger Keith
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.